Therapeutic Targeting of SPINK1-Positive Prostate Cancer
Intravasation
TMPRSS2
DOI:
10.1126/scitranslmed.3001498
Publication Date:
2011-03-04T13:21:56Z
AUTHORS (12)
ABSTRACT
SPINK1 is a therapeutic target in subset of patients with + /ETS − prostate cancer.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (35)
CITATIONS (131)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....